Author Archives: sobalas

“The RAGE of Diabetic Complications” will be the next Dynamic Duo seminar. Speakers will include Deebeanne M. Tavani, DO, PhD, FACE, System Chief of the Division of Endocrinology for Main Line Health; and Mel Reichman, PhD, Senior Investigator at Lankenau … Continue reading →

By Donna Loyle, communications specialist, LIMR The PRECISE cardiac trial seeks to assess clinical outcomes; decision making regarding noninvasive testing and invasive angiography; and costs of using a precision-evaluation strategy vs. a usual-care strategy in patients with stable symptoms of … Continue reading →

After many months of planning Main Line Heath will begin using Stryker Surgi-Count Radio Frequency Identification (RFID) in the Operating Rooms, Labor and Delivery, and C-Section Rooms commencing January 13, 2020. This technology will take our sponge tracking process to … Continue reading →

By Donna Loyle, communications specialist, LIMR Antibodies cloned by a team at the Lankenau Institute for Medical Research (LIMR), the research division of Main Line Health, and colleagues recently were adopted globally as the standard batch quality-control test for Sabin … Continue reading →

Join us for service events and a live-stream broadcast celebrating the life and legacy of Dr. Martin Luther King Jr. To view the noontime flyer, click here.

Main Line Health Information Services will be upgrading our Multi-Factor Authentication process that is used to verify users who are attempting to remotely access our systems. Multi-factor authentication sends a random 6-digit code to your registered mobile device when you remotely … Continue reading →

By Rick Mankin, MD, President, Main Line HealthCare Colleagues—I hope your New Year is off to a good start. The year of 2020 is one that will further put the tremendous expertise and service of our MLHC providers on the … Continue reading →

By Don Klingen, MD, CMIO Some of you may have already received communications from other regional health systems regarding the PAMA act and what’s needed to order outpatient radiology studies. The Protecting Access to Medicare Act of 2014 (PAMA) introduced … Continue reading →

By Donna Loyle, communications specialist, LIMR Can treatment with simple aspirin prevent breast cancer recurrence in patients with node-positive, HER2-negative, stage 2 or 3 breast cancer after chemotherapy, surgery and/or radiation therapy? That’s the question this trial seeks to answer. … Continue reading →